CARDIO KIDNEY METABOLIC
This Bayer grant funds clinician education projects on Cardio-Kidney-Metabolic syndrome, risk prediction, and evidence-based therapies using diverse educational formats.
Funder: Bayer
Due Dates: Rolling (monthly review; allow minimum 45 days for response)
Funding Amounts: Not specified; budget required in proposal; typical for medical education grants.
Summary: Supports clinician education on Cardio-Kidney-Metabolic syndrome, risk prediction, and evidence-based therapies.
Key Information: Proposals must comply with commercial support standards (e.g., ACCME) and include detailed educational plans.
Description
This grant program aims to advance clinician education related to Cardio-Kidney-Metabolic (CKM) syndrome. The focus is on enhancing understanding of CKM syndrome’s definition, stages, and the interconnected pathophysiology between cardiovascular and kidney diseases. The grant supports initiatives that promote evidence-based therapies offering both cardiac and kidney benefits, foster the use of risk prediction tools (such as UACR and eGFR), and align with current American Heart Association CKM guidelines. Educational projects may utilize a range of formats, including enduring materials, downloadable slides, podcasts, and live virtual events, with an emphasis on practical application in clinical practice.
